An epep collider based on proton-driven plasma wakefield acceleration

Recent simulations have shown that a high-energy proton bunch can excite strong plasma wakefields and accelerate a bunch of electrons to the energy frontier in a single stage of acceleration. This scheme could lead to a future $ep$ collider using the LHC for the proton beam and a compact electron accelerator of length 170 m, producing electrons of energy up to 100 GeV. The parameters of such a collider are discussed as well as conceptual layouts within the CERN accelerator complex. The physics of plasma wakefield acceleration will also be introduced, with the AWAKE experiment, a proof of principle demonstration of proton-driven plasma wakefield acceleration, briefly reviewed, as well as the physics possibilities of such an $ep$ collider.Comment: 6 pages, 2 figures, to appear in the proceedings of the DIS 2014 Workshop, 28 April - 2 May, Warsaw, Polan

Collider design issues based on proton-driven plasma wakefield acceleration

Recent simulations have shown that a high-energy proton bunch can excite strong plasma wakefields and accelerate a bunch of electrons to the energy frontier in a single stage of acceleration. It therefore paves the way towards a compact future collider design using the proton beams from existing high-energy proton machines, e.g. Tevatron or the LHC. This paper addresses some key issues in designing a compact electron-positron linear collider and an electron-proton collider based on existing CERN accelerator infrastructure

Broadband planar 90 degrees loaded-stub phase shifter

The differential phase shifter is an interesting four-port passive microwave network composed of two separate lines, the main line and the reference line, and providing stable phase difference between the two output signals over the specified bandwidth of interest. The most common differential phase shifter is the coupled-line Schiffman phase shifter. In this paper, a novel 90 degrees differential microstrip phase shifter configuration employing a half wavelength transmission line loaded with three open stubs is presented, the proposed design could achieve excellent performance with low phase variation over a wide bandwidth compared to the standard Schiffman phase shifter. The simulated results accomplished with the use of CST Microwave Studio and advanced design system (ADS), were found to be in good agreement and have shown that the proposed loaded-stub phase shifter achieved less than 1.1 dB insertion loss, greater than 13 dB return loss and constant 90±5 degrees phase shift over an 89 percent bandwidth

Native-valve tricuspid endocarditis due to Neisseria Sicca with bilateral pulmonary embolism

International audienceNo abstract availabl

Promoting the use of Motor Function Measure (MFM) as outcome measure in patients with Duchenne Muscular Dystrophy (DMD) treated by corticosteroids

ObjectivesAssessing muscle function is a key step in measuring changes and evaluating the outcomes of therapeutic interventions in Duchenne Muscular Dystrophy (DMD). Regarding the large use of corticosteroids (CS) in this population to delay the loss of function, our goal was to monitor the evolution of motor function in patients with DMD treated by corticosteroids (CS) and to study the responsiveness of Motor Function Measure (MFM) in this population in order to provide an estimation of the number of subject needed for a clinical trial.MethodA total of 76 patients with DMD, aged 5.9 to 11.8 years, with at least 6 months of follow-up and 2 MFM were enrolled, 30 in the CS treated group (8±1.62 y) and 46 in the untreated group (7.91±1.50 y).ResultsThe relationship between MFM scores and age was studied in CS treated patients and untreated patients. The evolution of these scores was compared between groups, on a 6-, 12- and 24-month period by calculating slopes of change and standardized response mean. At 6, 12 and 24 months, significant differences in the mean score change were found, for all MFM scores, between CS treated patients and untreated patients. For D1 subscore specifically, at 6 months, the increase is significant in the treated group (11.3±14%/y; SRM 0.8) while a decrease is observed in the untreated group (–17.8±17.7%/y; SRM 1). At 12 and 24 months, D1 subscore stabilized for treated patients but declined significantly for untreated boys (–15.5±15.1%/y; SRM 1 at 12 mo and–18.8±7.1%/y; SRM 2.6 at 24 mo). 21 patients lost the ability to walk during the study: 6 in the CS treated group (25% at 24 months, mean age: 10.74±1.28 y) and 15 in the untreated group (64.71% at 24 months, mean age: 9.20±1.78 y).Discussion and conclusionPatients with DMD treated by CS present a different course of the disease described in this paper using the MFM. Based on these results, an estimation of the number of patients needed for clinical trial could be done

Infrastructure for Detector Research and Development towards the International Linear Collider

The EUDET-project was launched to create an infrastructure for developing and testing new and advanced detector technologies to be used at a future linear collider. The aim was to make possible experimentation and analysis of data for institutes, which otherwise could not be realized due to lack of resources. The infrastructure comprised an analysis and software network, and instrumentation infrastructures for tracking detectors as well as for calorimetry.Comment: 54 pages, 48 picture